Yonjin Venture logo

Yonjin Venture

North America, Massachusetts, United States, Cambridge

Description

Yonjin Venture is an investment firm specializing in investing in early and mid-stage life science companies.

Investor Profile

Yonjin Venture has made 14 investments, with 3 in the past 12 months and 29% as lead.

Stage Focus

  • Series C (21%)
  • Series B (21%)
  • Series A (21%)
  • Series D (14%)
  • Series Unknown (7%)
  • Convertible Note (7%)
  • Undisclosed (7%)

Country Focus

  • United States (86%)
  • Israel (7%)
  • Belgium (7%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Medical Device
  • Therapeutics
  • Oncology
  • Health Diagnostics
  • Biopharma
  • Pharmaceutical
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yonjin Venture frequently co-invest with?

Elm Street Ventures
North America, Connecticut, United States, New Haven
Co-Investments: 2
Solasta Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 2
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Pfizer
North America, New York, United States, New York
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 3
RiverVest
North America, Missouri, United States, St Louis
Co-Investments: 2
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 3
State of Wisconsin Investment Board
North America, Wisconsin, United States, Madison
Co-Investments: 3
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 2

Which angels does Yonjin Venture often collaborate with?

TB
North America, Missouri, United States, St Louis
Shared Deals: 1

What are some of recent deals done by Yonjin Venture?

TECLens

New York, New York, United States

TECLens develops technology to treat keratoconus and correct vision problems.

Health CareMedical Device
Series AFeb 11, 2025
Amount Raised: $9,300,000
CSA Medical

Lutherville Timonium, Maryland, United States

CSA Medical is a provider of innovative spray cryotherapy medical device solutions.

BiotechnologyHealth CareMedicalMedical Device
Series DSep 9, 2024
Amount Raised: $53,000,000
HistoSonics

Plymouth, Minnesota, United States

HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.

Health CareMedicalMedical Device
Series DAug 15, 2024
Amount Raised: $102,000,000
EvolveImmune Therapeutics

Branford, Connecticut, United States

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series UnknownNov 16, 2023
Amount Raised: $37,398,371
HistoSonics

Plymouth, Minnesota, United States

HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.

Health CareMedicalMedical Device
Convertible NoteDec 13, 2022
Amount Raised: $85,000,000
Intressa Vascular

Isnes, Namur, Belgium

Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.

Health CareMedical
UndisclosedOct 25, 2022
Amount Raised: $11,954,585
Bluejay Therapeutics

San Mateo, California, United States

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

BiotechnologyHealth CarePharmaceutical
Series BAug 16, 2022
Amount Raised: $41,000,000
OncoResponse

Seattle, Washington, United States

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

BiopharmaBiotechnologyHealth CareOncologyTherapeutics
Series CMar 31, 2021
Amount Raised: $40,600,000
NanoCellect Biomedical

San Diego, California, United States

NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series CFeb 1, 2021
Amount Raised: $15,000,000
Libra Therapeutics

San Diego, California, United States

Libra Therapeutics is a biotechnology company.

BiotechnologyHealth Care
Series ASep 23, 2020
Amount Raised: $29,000,000